Rules concerning manufacture of clinical drugs to be eased
Published: 2007-12-27 06:58:00
Updated: 2007-12-27 06:58:00
The Korea Food and Drug Administration says the rules concerning the manufacturing of biological preparations for clinical use and their quality control would be eased in an attempt to ensure better health of subjects and support the nation's biotechnology sector.
In an information session on ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
